Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.

[1]  C. Petraki,et al.  Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer. , 2000, Anticancer research.

[2]  O. Yoshida,et al.  Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas. , 1999, The Journal of urology.

[3]  H. Kanayama,et al.  Prognostic values of matrix metalloproteinase‐2 and tissue inhibitor of metalloproteinase‐2 expression in bladder cancer , 1998 .

[4]  H. Miyake,et al.  Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. , 1997, The Journal of urology.

[5]  D. Grignon,et al.  High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. , 1996, Cancer research.

[6]  J. Foidart,et al.  High level of MT‐MMP expression is associated with invasiveness of cervical cancer cells , 1996, International journal of cancer.

[7]  W. Stetler-Stevenson,et al.  Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[9]  F. Sarkar,et al.  Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrence , 1994, International journal of cancer.

[10]  A. Shinagawa,et al.  Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1994, Journal of cell science.

[11]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[12]  A. Boag,et al.  Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. , 1994, The American journal of pathology.

[13]  A. Hanby,et al.  Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. , 1993, Cancer research.

[14]  J. Nemeth,et al.  TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts. , 1993, Experimental cell research.

[15]  D. Miles,et al.  Activity of type IV collagenases in benign and malignant breast disease. , 1993, British Journal of Cancer.

[16]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  H. Miyake,et al.  Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. , 2000, Cancer research.

[18]  I. Talbot,et al.  Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. , 1996, Cancer research.